Skip to content
MRI Brain

SG-FCCM

SWI dataset of familial cerebral cavernous malformations (Fuzhou University and Fujian Medical University)

101 SWI brain volumes from 73 patients with familial cerebral cavernous malformations, 26 with a 1-year follow-up, sliced into 4,089 2D images with lesion masks. Described in a paper with public code and weights; the data are not released.

Overview

SG-FCCM is a set of susceptibility-weighted brain MRI scans of patients with familial cerebral cavernous malformation, a hereditary disease that produces many small, blood-filled vascular lesions in the brain. A group from Fuzhou University and the First Affiliated Hospital of Fujian Medical University in China built it to develop a pipeline that annotates, segments, counts and measures the lesions and compares them between two examinations of the same patient. The code and trained U-Net weights are on GitHub; the images and masks are not, and the preprint contains no data availability statement.

Composition

101 SWI volumes from 73 patients, of whom 26 have a scan at enrolment and another one year later. The volumes were cut into 4,089 2D images of 768 x 768 pixels. The paper split these images at random into 3,289 for training, 400 for validation and 400 for testing, and does not say whether the split kept each patient in one set. Age, sex and genotype are not reported.

Acquisition

All volumes come from one SWI protocol: TR 31 ms, TE 7.2 ms with an echo spacing of 6.2 ms, field of view 200 x 230 mm, matrix 384 x 332, 130 slices of 2 mm. The preprint names neither the scanner nor the field strength.

Annotations

Lesions were segmented as 2D masks per slice. For 1,579 images from 39 volumes, annotators drew boxes around lesions and turned them into masks with the Segment Anything Model or a threshold inside each box; physicians accepted 1,378 of these. The rest were labelled by repeatedly training a segmentation network and keeping the predictions that passed screening. Doctors corrected the 561 masks that stayed unsatisfactory by hand.

Known limitations

  • The data are not shared and no terms exist; access, if any, is at the authors' discretion.
  • Counts come from the arXiv preprint (v1). The journal version reports a different Dice score in its abstract and may describe the data differently; its full text was not checked.
  • Masks are partly model-generated, and a random slice-level split can place slices of one patient in both training and test sets.
  • Scanner, field strength and demographics are unknown.

Cohort

Aggregate numbers from the sources below. Bars are relative to the 73 subjects.

Contrast / sequence

subjects, values can overlap

  • Susceptibility-weighted 73 100%

Condition

subjects, values can overlap

  • Cerebral cavernous malformation 73 100%

Split

images

  • Training 3,289 80%
  • Validation 400 10%
  • Test 400 10%

License and access

Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer

Access
On request

Ask the authors or the data holder. No published process or terms, and access is at their discretion

Access page

No published license or data use terms

The data holder has published no license and no data use terms. Any use, sharing or commercial right has to be agreed with the data holder, and nothing can be assumed to be allowed. Default copyright and data protection law still apply.

The preprint has no data availability statement. The code repository shares code and U-Net weights but no images or masks, and has no license file.

Original license text Checked 2026-10-08

What you can do

  • Commercial use Not stated
  • Train ML models Not stated
  • Create derived data Not stated
  • Publish results Not stated

What you can share

  • Share the data Not stated
  • Share derived data Not stated
  • Share trained models Not stated

What you must do

  • Cite or credit Not stated
  • Share alike Not stated
  • Sign an agreement Not stated
  • Ethics approval Not stated
  • Manuscript review Not stated
  • Release code Not stated
  • Return results Not stated
  • Delete after use Not stated

Limits

  • No re-identification Not stated
  • Location limits Not stated

Citation

Zong R, Wang T, Li C, et al. Innovative Quantitative Analysis for Disease Progression Assessment in Familial Cerebral Cavernous Malformations. IEEE Trans Biomed Eng 72(7), 2269-2282 (2025). doi:10.1109/TBME.2025.3539498

All numbers

Every number on this page, as stored in stats.csv, with its source.

MeasureBreakdownValueSource
Subjectstotal 73zong2024
Section 3.1
Scanstotal
SWI volumes; 26 patients have an enrolment and a 1-year follow-up scan
101zong2024
Section 3.1
Imagestotal
2D slices of 768 x 768 pixels taken from the volumes
4,089zong2024
Section 3.1
Subjectscondition=cerebral_cavernous_malformation
familial form
73zong2024
Section 3.1
Subjectscontrast=swi 73zong2024
Section 3.1
Imagessplit=train
random split at slice level
3,289zong2024
Section 3.1
Imagessplit=validation 400zong2024
Section 3.1
Imagessplit=test 400zong2024
Section 3.1

Sources

The keys used in the table above.